HAWTHORNE, N.Y., May 20, 2024--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024
NEW YORK, May 08, 2024--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
NEW YORK, April 15, 2024--Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.